Sign in

CIK 0001041024

  • Non-accelerated filer
  • Smaller reporting company

ROCKWELL MEDICAL, INC.

Sign in to watch
Ticker
RMTI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
383317208
Phone
+1 800-449-3353
Business address
30142 WIXOM ROAD, WIXOM, MI, 48393
Former names
ROCKWELL MEDICAL TECHNOLOGIES INC
  1. 4 Grant or award Director acquired 9,800 shares (grant or award)
  2. 4 Grant or award VP of Drug Development acquired 68,500 shares (grant or award)
  3. 4 Grant or award Chief Scientific Officer acquired 68,500 shares (grant or award)
  4. 4 Grant or award Chairman, President and CEO acquired 245,000 shares (grant or award)
  5. 4 Grant or award Vice President, CFO acquired 68,600 shares (grant or award)
  6. 4 Open-market buy 10% owner bought 37,210 shares at an average $5.84 ($217,492)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale Director sold 6,000 shares at an average $5.98 ($35,871)
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market sale Director sold 19,725 shares at an average $5.16 ($101,687)
  12. 4 Open-market sale Director sold 1,400 shares at $5.92 ($8,288)
  13. 4 Open-market sale Director sold 2,533 shares at an average $6.04 ($15,299)
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market sale Director sold 8,075 shares at an average $6.81 ($54,977)
  16. 4 Open-market sale Director sold 9,520 shares at an average $6.37 ($60,656)
  17. 4 Open-market sale Director sold 3,692 shares at an average $7.31 ($26,991)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Exercise or conversion Director acquired 25,000 shares (option exercise)
  20. 4 Shares withheld for taxes Vice President, CFO gave up 61,250 shares (to pay taxes)

Page 11 of 24 · 470 filings